Asia Morning: Dow, S&P500 at Record Levels

The Russell 2000 Index (+2.37%) also closes at record high...

Trading floor 2

On Monday, U.S. stocks maintained upward momentum pushing the Dow Jones Industrial Average (+470 points or 1.60% to 29950) and the S&P 500 (+41 points or 1.16% to 3626) to record levels. The Nasdaq 100 rose 75 points (+0.63%) to 12013.

At the same time, the Russell 2000 Index (+41 points or 2.37% to 1785) also closed at record high.


S&P 500 Index (Daily Chart) : Fresh Record High

Sources: GAIN Capital, TradingView


The key market driver was Moderna's (MRNA +9.58%) announcement of positive trial results of its COVID-19 vaccine.

Energy (+6.5%), Automobiles & Components (+3.01%) and Banks (+2.95%) sectors performed the best. Energy companies such as Schlumberger (SLB +10.89%), National Oilwell Varco (NOV +9.38%) and HollyFrontier (HFC +9.24%) were top gainers along with a 3% gain in as oil prices.

Approximately 87% (82% in the prior session) of stocks in the S&P 500 Index were trading above their 200-day moving average and 86% (80% in the prior session) were trading above their 20-day moving average.

In after-market hours, Tesla (TSLA) soared over 10% after S&P Dow Jones Indices announced that the stock will join the S&P 500 Index in December.

European stocks were broadly higher. The Stoxx Europe 600 rose 1.18%, Germany's DAX added 0.47%, France's CAC 40 jumped 1.70%, and the U.K.'s FTSE 100 was up 1.66%.

U.S. Treasury prices remained under pressure, as the benchmark 10-year Treasury yield climbed further to 0.904% from 0.893% Friday.

Spot gold edged up to $1,889 an ounce.

Oil prices jumped as economic recovery hopes were boosted by positive news concerning Moderna's vaccine candidate. U.S. WTI crude futures (December) jumped $1.27 (+3.16%) to $41.4 a barrel.

The U.S. dollar kept weakening against other major currencies as investors' risk appetite was enlarged by another positive development on a COVID-19 vaccine. The ICE Dollar Index slipped 0.17% to 92.55.

EUR/USD was up for a third session rising 0.15% to 1.1851.

USD/JPY edged down to 104.58, testing support at its 20-day moving average. Official data showed that Japan's 3Q GDP rose at an annualized rate of 21.4% on quarter (+18.9% expected).

GBP/USD closed flat at 1.3197.

Commodity-related currencies strengthened against the greenback. AUD/USD jumped 0.69% to 0.7320, up for a second session. 

USD/CAD slid 0.48% to 1.3074.

More from Commodities

Join our live webinars for the latest analysis and trading ideas. Register now

GAIN Capital UK Limited (trading as “City Index”) is an execution-only service provider. This material, whether or not it states any opinions, is for general information purposes only and it does not take into account your personal circumstances or objectives. This material has been prepared using the thoughts and opinions of the author and these may change. However, City Index does not plan to provide further updates to any material once published and it is not under any obligation to keep this material up to date. This material is short term in nature and may only relate to facts and circumstances existing at a specific time or day. Nothing in this material is (or should be considered to be) financial, investment, legal, tax or other advice and no reliance should be placed on it.

No opinion given in this material constitutes a recommendation by City Index or the author that any particular investment, security, transaction or investment strategy is suitable for any specific person. The material has not been prepared in accordance with legal requirements designed to promote the independence of investment research. Although City Index is not specifically prevented from dealing before providing this material, City Index does not seek to take advantage of the material prior to its dissemination. This material is not intended for distribution to, or use by, any person in any country or jurisdiction where such distribution or use would be contrary to local law or regulation.

For further details see our full non-independent research disclaimer and quarterly summary.